Simvastatin News
Merck Loses Protection for Patent on Zocor
This is the day that Merck — and Pfizer — have long dreaded. Today, Merck's cholesterol-lowering drug Zocor loses its United States patent protection, becoming the largest-selling drug yet to be opened to cheap generic...
Reports from the People's Republic of China and Canada add new data to cardiology research
Data on cardiology are outlined in reports from the People's Republic of China and Canada.
Ezetimibe + simvastatin as initial therapy in chronic kidney disease adds LDL-lowering benefit
The addition of ezetimibe to simvastatin as initial therapy for patients with chronic kidney disease was well tolerated and produced an additional 21% decrease in LDL cholesterol levels.
Simvastatin improves hemodynamic responses to ischemia-reperfusion
Since simvastatin at a concentration lower than 100 mcmol/l exerted beneficial effects on cardiac function in isolated perfused rat hearts, it could be applied just after myocardial ischemia and reperfusion
Diabetic Eye Health – Statin drugs may help improve blood circulation possibly preventing diabetic retinopathy and blindness
Researchers from Japan studied how simvastatin drug would effect blood circulation in the eye. The study was first reported in the Archives of Ophthalmology.